Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Conformational and functional variants of CD44-targeted protein nanoparticles bio-produced in bacteria.

Pesarrodona M, Fernández Y, Foradada L, Sánchez-Chardi A, Conchillo-Solé O, Unzueta U, Xu Z, Roldán M, Villegas S, Ferrer-Miralles N, Schwartz S, Rinas U, Daura X, Abasolo I, Vázquez E, Villaverde A.

Biofabrication. 2016 Apr 14;8(2):025001. doi: 10.1088/1758-5090/8/2/025001.

PMID:
27078873
2.

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli.

Rueda F, Céspedes MV, Sánchez-Chardi A, Seras-Franzoso J, Pesarrodona M, Ferrer-Miralles N, Vázquez E, Rinas U, Unzueta U, Mamat U, Mangues R, García-Fruitós E, Villaverde A.

Microb Cell Fact. 2016 Apr 8;15(1):59. doi: 10.1186/s12934-016-0457-z.

3.

Biphasic modulation of Wnt signaling supports efficient foregut endoderm formation from human pluripotent stem cells.

Hoepfner J, Kleinsorge M, Papp O, Ackermann M, Alfken S, Rinas U, Solodenko W, Kirschning A, Sgodda M, Cantz T.

Cell Biol Int. 2016 May;40(5):534-48. doi: 10.1002/cbin.10590. Epub 2016 Feb 25.

PMID:
26861571
4.

Assessing stability and assembly of the hepatitis B surface antigen into virus-like particles during down-stream processing.

Zahid M, Lünsdorf H, Rinas U.

Vaccine. 2015 Jul 17;33(31):3739-45. doi: 10.1016/j.vaccine.2015.05.066. Epub 2015 Jun 12.

PMID:
26079614
5.

Smart sustainable bottle (SSB) system for E. coli based recombinant protein production.

Li Z, Carstensen B, Rinas U.

Microb Cell Fact. 2014 Nov 5;13:153. doi: 10.1186/s12934-014-0153-9.

6.

The metabolic potential of Escherichia coli BL21 in defined and rich medium.

Li Z, Nimtz M, Rinas U.

Microb Cell Fact. 2014 Mar 23;13(1):45. doi: 10.1186/1475-2859-13-45.

7.
8.

Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress.

Ricke-Hoch M, Bultmann I, Stapel B, Condorelli G, Rinas U, Sliwa K, Scherr M, Hilfiker-Kleiner D.

Cardiovasc Res. 2014 Mar 15;101(4):587-96. doi: 10.1093/cvr/cvu010. Epub 2014 Jan 20.

9.

Improving protein delivery of fibroblast growth factor-2 from bacterial inclusion bodies used as cell culture substrates.

Seras-Franzoso J, Peebo K, García-Fruitós E, Vázquez E, Rinas U, Villaverde A.

Acta Biomater. 2014 Mar;10(3):1354-9. doi: 10.1016/j.actbio.2013.12.021. Epub 2013 Dec 19.

PMID:
24361427
10.

Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties.

Gurramkonda C, Zahid M, Nemani SK, Adnan A, Gudi SK, Khanna N, Ebensen T, Lünsdorf H, Guzmán CA, Rinas U.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Dec 1;940:104-11. doi: 10.1016/j.jchromb.2013.09.030. Epub 2013 Sep 27.

PMID:
24141044
11.

Metabolic costs of amino acid and protein production in Escherichia coli.

Kaleta C, Schäuble S, Rinas U, Schuster S.

Biotechnol J. 2013 Sep;8(9):1105-14. doi: 10.1002/biot.201200267. Epub 2013 Jul 15.

PMID:
23744758
12.

Dengue-specific subviral nanoparticles: design, creation and characterization.

Khetarpal N, Poddar A, Nemani SK, Dhar N, Patil A, Negi P, Perween A, Viswanathan R, Lünsdorf H, Tyagi P, Raut R, Arora U, Jain SK, Rinas U, Swaminathan S, Khanna N.

J Nanobiotechnology. 2013 May 25;11:15. doi: 10.1186/1477-3155-11-15.

13.

A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs.

Seras-Franzoso J, Peebo K, Luis Corchero J, Tsimbouri PM, Unzueta U, Rinas U, Dalby MJ, Vazquez E, García-Fruitós E, Villaverde A.

Nanomedicine (Lond). 2013 Oct;8(10):1587-99. doi: 10.2217/nnm.12.188. Epub 2013 Feb 8.

PMID:
23394133
14.

Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies.

Cano-Garrido O, Rodríguez-Carmona E, Díez-Gil C, Vázquez E, Elizondo E, Cubarsi R, Seras-Franzoso J, Corchero JL, Rinas U, Ratera I, Ventosa N, Veciana J, Villaverde A, García-Fruitós E.

Acta Biomater. 2013 Apr;9(4):6134-42. doi: 10.1016/j.actbio.2012.11.033. Epub 2012 Dec 7.

PMID:
23220450
15.

Folding and dimerization kinetics of bone morphogenetic protein-2, a member of the transforming growth factor-β family.

Vallejo LF, Rinas U.

FEBS J. 2013 Jan;280(1):83-92. doi: 10.1111/febs.12051. Epub 2012 Nov 22.

16.

Physiological response of Pichia pastoris GS115 to methanol-induced high level production of the Hepatitis B surface antigen: catabolic adaptation, stress responses, and autophagic processes.

Vanz AL, Lünsdorf H, Adnan A, Nimtz M, Gurramkonda C, Khanna N, Rinas U.

Microb Cell Fact. 2012 Aug 8;11:103. doi: 10.1186/1475-2859-11-103.

17.

Packaging protein drugs as bacterial inclusion bodies for therapeutic applications.

Villaverde A, García-Fruitós E, Rinas U, Seras-Franzoso J, Kosoy A, Corchero JL, Vazquez E.

Microb Cell Fact. 2012 Jun 11;11:76. doi: 10.1186/1475-2859-11-76.

18.

Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies.

Vázquez E, Corchero JL, Burgueño JF, Seras-Franzoso J, Kosoy A, Bosser R, Mendoza R, Martínez-Láinez JM, Rinas U, Fernández E, Ruiz-Avila L, García-Fruitós E, Villaverde A.

Adv Mater. 2012 Apr 3;24(13):1742-7. doi: 10.1002/adma.201104330. Epub 2012 Mar 13.

PMID:
22410789
19.

Inclusion bodies of fuculose-1-phosphate aldolase as stable and reusable biocatalysts.

Sans C, García-Fruitós E, Ferraz RM, González-Montalbán N, Rinas U, López-Santín J, Villaverde A, Álvaro G.

Biotechnol Prog. 2012 Mar-Apr;28(2):421-7. doi: 10.1002/btpr.1518. Epub 2012 Feb 10.

PMID:
22275283
20.

Analysis and Design of Stimulus Response Curves of E. coli.

Kremling A, Goehler A, Jahreis K, Nees M, Auerbach B, Schmidt-Heck W, Kökpinar O, Geffers R, Rinas U, Bettenbrock K.

Metabolites. 2012 Nov 12;2(4):844-71. doi: 10.3390/metabo2040844.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk